infrastructureScore 35/100Research
US legislation to restrict Chinese robotics adoption in domestic market likely to pass with bipartisan support; protects domestic robotics players from cost competition.
Andrew Kang· Mechanism Capital· Robotics· 2026-07-31· about Chinese robotics companies (GBOT, AgiBOT), US-based robotics companies (Figure AI, Boston Dynamics)
“there are a few bills going through Congress right now to help leaders restrict Chinese robots within America. And I think there are kind of two components of this. One is national security issue... and the idea that of course you want to promote the domestic industry. And so this is something that is getting a lot of bipartisan support and I don't think it's I think it's very high probability that a bill like this passes.”
Why it matters
A likely legislative moat for US robotics companies eliminates the largest competitive threat (lower-cost Chinese alternatives). This is a structural, regulatory de-risking of US humanoid robotics investments and a material tailwind for domestic hardware companies.
Investment implication
US-based robotics companies and their supply chain partners (actuators, sensors, manufacturing) benefit from protected domestic market (30–60% of global robotics value). Chinese robotics and component suppliers lose US market access; Asian suppliers to Chinese firms face margin compression. This effectively subsidizes US robotics scaling.